Metrics as of 10/17/2026, 06:14 AM (Berlin time), refresh in progress.
Bristol-Myers Squibb Company Stock
Bristol-Myers Squibb Company
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United States
- CEO
- Christopher Boerner
- Employees
- 32,500
- Market cap
- $122.1 B
- IPO
- 01/06/1972
- Web
- www.bms.com
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions,…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Bristol-Myers Squibb Company stock: price history
1D
-1.4%
1W
+1.1%
1M
-6.1%
6M
-0.7%
YTD
+10.8%
1Y
+37.7%
2Y
+12.0%
5Y
+2.4%
10Y
+20.1%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~41% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Bristol-Myers Squibb Company
Analyst assessment of Bristol-Myers Squibb Company
PRICE TARGET LOW
US$41.00
CONSENSUS
US$66.08
MEDIAN
US$65.00
PRICE TARGET HIGH
US$82.00
0
STRONG BUY
19
BUY
21
HOLD
2
SELL
0
STRONG SELL
42
TOTAL · Hold
As of: 13/10/2026
Bristol-Myers Squibb Company stock metrics
P/E
13.16
P/B
5.47
EV/EBITDA
9.3
RETURN ON EQUITY
14.9%
NET MARGIN
25.6%
DEBT/EQUITY
1.93
DIVIDEND YIELD
4.2%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.8%
FLOAT SHARES
2,039,548,448
AVG. DAILY VOLUME (30D)
12,750,577
Insider transactions (SEC)
Gallman Cari
Gallman Cari
Massacesi Cristian
Short Bartie Wendy
Short Bartie Wendy
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.4%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Bristol-Myers Squibb Company stock
What does Bristol-Myers Squibb Company do?
Bristol-Myers Squibb Company is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United States.
The CEO is Christopher Boerner, the company employs around 32,500 people.
The IPO was on 01/06/1972; the stock trades on NYSE under the ticker BMY.
What do analysts say about Bristol-Myers Squibb Company stock?
42 analysts rate the stock, the consensus is Hold (as of 13/10/2026).
The average price target is US$66.08, ranging from US$41.00 to US$82.00, with a median of US$65.00.
This is an external assessment, not a statement by Market Jury.
When does Bristol-Myers Squibb Company report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 41% stronger than usual.
Does Bristol-Myers Squibb Company pay a dividend?
Yes. The last dividend was US$0.63 per share, ex-date 02/10/2026, paid on 02/11/2026.
The dividend yield is 4.2% (as of 30/06/2026).
Which stocks are comparable to Bristol-Myers Squibb Company?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Biogen.
How can I get Bristol-Myers Squibb Company stock analyzed?
Clicking "Analyze stock" lets five strategies assess Bristol-Myers Squibb Company against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.